Clinical Trial Update: A Pharmacokinetic and Pharmacodynamic Study of MabThera (Rituximab) Plus Methotrexate in Patients With Rheumatoid Arthritis (RA) [Phase 2]

View source ↗

Summary

This is a Phase 2 pharmacokinetic/pharmacodynamic study of MabThera (rituximab) plus methotrexate in rheumatoid arthritis; the trial was terminated and results …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• METHOTREXATE (METHOTREXATE)
• MabThera (rituximab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Rheumatoid Arthritis | Phase 2 | Status: TERMINATED | Results posted: 2014-07-16